Cannabinoid Oral Mucosal Delivery: Approaches to Formulation, Fabrication, and Permeation Enhancement
Date
Authors
Nagaraj, Anushree
Seyfoddin, Ali
Supervisor
Item type
Journal Article
Degree name
Journal Title
Journal ISSN
Volume Title
Publisher
Springer Science and Business Media LLC
Abstract
Cannabinoids such as cannabidiol (CBD) and tetrahydrocannabinol (THC) have garnered significant interest for their broad-spectrum pharmacological activity in managing chronic pain, neurological disorders, and cancer-associated symptoms. Despite their therapeutic promise, clinical translation remains hindered by poor aqueous solubility, extensive first-pass metabolism, and inconsistent systemic exposure following oral administration. Oral mucosal drug delivery systems offer a viable alternative by enabling transmucosal absorption, bypassing hepatic metabolism, and facilitating both rapid and sustained drug release. This review examines the evolution and design of oral mucosal dosage forms, including fast-dissolving films, mucoadhesive matrices, in situ gels, and particulate systems and highlights the critical role of formulation strategies in enhancing cannabinoid bioavailability. Fabrication techniques such as solvent casting, hot melt extrusion, and emerging 3D printing methods are also discussed, with a focus on their potential to enable personalized dosage forms. Furthermore, the integration of permeation enhancers like terpenes, and novel systems such as inclusion complexes and lipid-based carriers, presents new opportunities for improving the solubility and stability of lipophilic cannabinoids. Together, these innovations provide a framework for the development of stable, effective, and patient-centric oral mucosal cannabinoid delivery platforms with improved pharmacokinetic and therapeutic profiles.Description
Keywords
cannabidiol (CBD), formulation strategies, oral mucosal delivery, sustained release, tetrahydrocannabinol (THC), 3214 Pharmacology and Pharmaceutical Sciences, 3206 Medical Biotechnology, 32 Biomedical and Clinical Sciences, Dental/Oral and Craniofacial Disease, Natural Products, Biotechnology, Therapeutic Cannabinoid Research, Complementary and Integrative Health, Cannabidiol Research, 5.1 Pharmaceuticals, 3 Good Health and Well Being, 1115 Pharmacology and Pharmaceutical Sciences, Pharmacology & Pharmacy
Source
AAPS PharmSciTech, ISSN: 0163-5158 (Print); 1530-9932 (Online), Springer Science and Business Media LLC, 27(3), 132-. doi: 10.1208/s12249-026-03380-z
Publisher's version
Rights statement
Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.